Diagnostics firm secures €2m for blood test for pregnant women

Clockwise from left: Frank Walsh, partner, Enterprise Equity; Bill Liao, European investment partner, SOSventures; Charles Garvey, chief executive, Metabolomic Diagnostics; and Professor Louise Kenny, consultant obstetrician at CUMH and director of the INFANT Centre with four-day-old baby Molly

Company: Metabolomic Diagnostics

Done Deal:€2 million EU funding

The clincher:“We plan to market the product next year, and with this support from EU, we believe that PrePsia has the potential to become part of pregnancy screening programmes worldwide” - Charles Garvey, chief executive, Metabolomic Diagnostics

Biotech start-up Metabolomic Diagnostics has secured €2 million in EU funding under the Horizon 2020 SME Instrument.

The Cork company is developing a blood test, which can be ...